Greenland Capital Management LP Takes Position in CVS Health Co. (NYSE:CVS)

Greenland Capital Management LP purchased a new position in shares of CVS Health Co. (NYSE:CVS - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 5,644 shares of the pharmacy operator's stock, valued at approximately $253,000.

Other large investors also recently added to or reduced their stakes in the company. Ridgewood Investments LLC raised its position in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after purchasing an additional 450 shares during the period. Stonebridge Financial Group LLC purchased a new stake in shares of CVS Health during the fourth quarter worth $28,000. Hopwood Financial Services Inc. bought a new position in shares of CVS Health in the fourth quarter worth $29,000. Financial Perspectives Inc grew its position in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after purchasing an additional 466 shares in the last quarter. Finally, MidAtlantic Capital Management Inc. raised its stake in shares of CVS Health by 112.1% during the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock valued at $37,000 after purchasing an additional 437 shares during the period. Hedge funds and other institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of recent analyst reports. Piper Sandler lifted their target price on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a report on Friday, March 21st. Argus set a $77.00 price objective on shares of CVS Health in a research note on Tuesday, February 18th. Leerink Partnrs upgraded shares of CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 12th. Mizuho upped their price target on shares of CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Finally, JPMorgan Chase & Co. lifted their price objective on CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a research note on Tuesday, February 18th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, CVS Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $71.28.

CVS Health Trading Down 0.1 %

Shares of CVS traded down $0.05 during trading hours on Monday, hitting $69.46. The company had a trading volume of 2,656,201 shares, compared to its average volume of 11,310,602. The firm has a market cap of $87.57 billion, a P/E ratio of 18.98, a P/E/G ratio of 0.98 and a beta of 0.57. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $71.66. The stock's 50 day moving average price is $65.10 and its 200 day moving average price is $58.51. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, research analysts predict that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Tuesday, April 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.83%. CVS Health's payout ratio is presently 72.68%.

Insider Buying and Selling at CVS Health

In related news, Director Michael F. Mahoney purchased 30,000 shares of CVS Health stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now directly owns 39,356 shares of the company's stock, valued at $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the sale, the senior vice president now owns 8,394 shares of the company's stock, valued at $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.24% of the stock is currently owned by corporate insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.